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Background: In senescent heart, β-adrenergic response is altered in parallel with β1-
and β2-adrenoceptor down-regulation. A negative inotropic effect of β3-adrenoceptor
could be involved. In this study, the authors tested the hypothesis that β3-
adrenoceptor plays a role in β-adrenergic dysfunction in senescent heart.Methods: β-
Adrenergic responses were investigated in vivo (echocardiography–dobutamine,
electron paramagnetic resonance) and in vitro (isolated left ventricular papillary
muscle, electron paramagnetic resonance) in young adult (3-month-old) and
senescent (24-month-old) rats. Nitric oxide synthase (NOS) immunolabeling (confocal
microscopy), nitric oxide production (electron paramagnetic resonance) and β-
adrenoceptor Western blots were performed in vitro. Data are mean percentages of
baseline ± SD. Results: An impaired positive inotropic effect (isoproterenol) was
confirmed in senescent hearts in vivo (117 ± 23 vs. 162 ± 16%; P < 0.05) and in vitro
(127 ± 10 vs. 179 ± 15%; P < 0.05). In the young adult group, the positive inotropic
effect was not significantly modified by the nonselective NOS inhibitor NG-nitro-l-
arginine methylester (l-NAME; 183 ± 19%), the selective NOS1 inhibitor vinyl-l-
N-5(1-imino-3-butenyl)-l-ornithine (l-VNIO; 172 ± 13%), or the selective NOS2
inhibitor 1400W (183 ± 19%). In the senescent group, in parallel with β3-
adrenoceptor up-regulation and increased nitric oxide production, the positive
inotropic effect was partially restored by l-NAME (151 ± 8%; P < 0.05) and l-VNIO
(149 ± 7%; P < 0.05) but not by 1400W (132 ± 11%; not significant). The positive
inotropic effect induced by dibutyryl-cyclic adenosine monophosphate was decreased
in the senescent group with the specific β3-adrenoceptor agonist BRL 37344 (167 ±
10 vs. 142 ± 10%; P < 0.05). NOS1 and NOS2 were significantly up-regulated in the
senescent rat. Conclusions: In senescent cardiomyopathy, β3-adrenoceptor
overexpression plays an important role in the altered β-adrenergic response via


















Publié sur Okina (http://okina.univ-angers.fr)
